Ieq Capital LLC Purchases 2,190 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Ieq Capital LLC boosted its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 8.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 27,497 shares of the medical device company’s stock after acquiring an additional 2,190 shares during the period. Ieq Capital LLC’s holdings in Cooper Companies were worth $2,528,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also modified their holdings of the business. Ashton Thomas Securities LLC bought a new position in shares of Cooper Companies in the third quarter valued at $25,000. Covestor Ltd raised its stake in Cooper Companies by 144.9% in the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after acquiring an additional 200 shares during the period. Byrne Asset Management LLC acquired a new stake in Cooper Companies during the 4th quarter valued at $33,000. Brown Brothers Harriman & Co. boosted its position in Cooper Companies by 191.0% during the third quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock worth $46,000 after purchasing an additional 275 shares during the period. Finally, West Financial Advisors LLC acquired a new position in shares of Cooper Companies in the fourth quarter valued at $49,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Stock Down 0.2 %

NASDAQ COO opened at $88.48 on Monday. The Cooper Companies, Inc. has a fifty-two week low of $84.76 and a fifty-two week high of $112.38. The business has a fifty day moving average price of $92.94 and a two-hundred day moving average price of $99.66. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The stock has a market capitalization of $17.66 billion, a PE ratio of 45.37, a PEG ratio of 2.25 and a beta of 1.00.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.04. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Cooper Companies’s revenue was up 9.8% compared to the same quarter last year. During the same period last year, the firm posted $0.87 earnings per share. Equities analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Morgan Stanley reduced their price objective on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. Citigroup lowered their target price on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research note on Friday, December 6th. StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Finally, Wells Fargo & Company increased their price objective on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Three research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $117.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.